David Platt - Nov 19, 2021 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
/s/ David Platt
Stock symbol
BIXT
Transactions as of
Nov 19, 2021
Transactions value $
-$393,790
Form type
4
Date filed
1/18/2022, 12:59 PM
Previous filing
Jun 7, 2021
Next filing
Jan 28, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT Common Gift -$442K -3.2M -6.93% $0.14 43M Nov 19, 2021 Direct F1
transaction BIXT Common Award $4.14K +2.07M $0.00* 2.07M Dec 3, 2021 by NDPD Pharma, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIXT Warrants Award $43.9K +122K $0.36 122K May 2, 2021 Common 122K $2.00 by NDPD Pharma, Inc. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares returned to Company's treasury
F2 The warrant agreement includes provisions for dilutive issuance and cash-less exercise